» Articles » PMID: 33154770

CLC-3 and SOX2 Regulate the Cell Cycle in DU145 Cells

Overview
Journal Oncol Lett
Specialty Oncology
Date 2020 Nov 6
PMID 33154770
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Sex determining region Y-box 2 (SOX2) is a transcription factor that serves a role in numerous different types of malignant cancer. Altered expression of chloride channel proteins has been described in a variety of malignancies. However, the association between SOX2 and chloride channel proteins is not yet fully understood. The present study investigated the association between SOX2 and chloride voltage-gated channel 3 (CLC-3) in prostate cancer. Flow cytometry demonstrated that the inactivation of CLC-3 or SOX2 arrested cell cycle progression in the G/G phase. Furthermore, CLC-3 was observed to bind to SOX2, and vice versa, by co-immunoprecipitation. SOX2 appears to initiate and maintain prostate cancer tumorigenesis, in part, by modulating the cell cycle. These findings indicate the potential of SOX2 and CLC-3 as targets for the development of multi-targeted therapeutics.

Citing Articles

The molecular pathogenesis of SOX2 in prostate cancer.

Liu S, Yu H, Zhao Z Discov Oncol. 2025; 16(1):215.

PMID: 39976818 PMC: 11842661. DOI: 10.1007/s12672-025-01972-y.


SOX2 regulates paclitaxel resistance of A549 non‑small cell lung cancer cells via promoting transcription of ClC‑3.

Huang Y, Wang X, Hu R, Pan G, Lin X Oncol Rep. 2022; 48(4).

PMID: 36069232 PMC: 9478990. DOI: 10.3892/or.2022.8396.


ClC-c regulates the proliferation of intestinal stem cells via the EGFR signalling pathway in Drosophila.

Huang J, Sheng X, Zhuo Z, Xiao D, Wu K, Wan G Cell Prolif. 2021; 55(1):e13173.

PMID: 34952996 PMC: 8780901. DOI: 10.1111/cpr.13173.

References
1.
McCalmont W, Heady T, Patterson J, Lindenmuth M, Haverstick D, Gray L . Design, synthesis, and biological evaluation of novel T-Type calcium channel antagonists. Bioorg Med Chem Lett. 2004; 14(14):3691-5. DOI: 10.1016/j.bmcl.2004.05.011. View

2.
Lee S, Kwon M, Jang J, Sohng J, Jung H . The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells. Int J Oncol. 2017; 51(2):414-424. PMC: 5505016. DOI: 10.3892/ijo.2017.4054. View

3.
Liu Z, Zhang W, Phillips J, Arora R, McClellan S, Li J . Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation. Oncogene. 2018; 38(1):88-102. PMC: 6318029. DOI: 10.1038/s41388-018-0407-9. View

4.
Suh K, Malik M, Shukla A, Yuspa S . CLIC4, skin homeostasis and cutaneous cancer: surprising connections. Mol Carcinog. 2007; 46(8):599-604. DOI: 10.1002/mc.20324. View

5.
Xu B, Mao J, Wang L, Zhu L, Li H, Wang W . ClC-3 chloride channels are essential for cell proliferation and cell cycle progression in nasopharyngeal carcinoma cells. Acta Biochim Biophys Sin (Shanghai). 2010; 42(6):370-80. DOI: 10.1093/abbs/gmq031. View